New Science Ventures (NSV) is a venture capital firm based in Connecticut and London that specializes in investing in early and late-stage companies in the Life Sciences and Information Technology sectors. They focus on companies that utilize novel scientific approaches to address significant unmet needs. NSV aims to create value by supporting breakthrough science and innovation.
One of the companies they have invested in is biomodal, an omics-based life sciences technology and analytics company. biomodal recently announced a powerful new multiomic solution called duet evoC, which delivers the 6-base genome and provides unprecedented insights into current and future states of disease using a single 5ng DNA sample. This technology has the potential to revolutionize the field of genomics and advance our understanding of various diseases.
Generated from the website